https://endpts.com/the-ema-gives-the-thumbs-down-to-gsks-bone-marrow-cancer-drug-ptcs-duchenne-candidate/
end points ( one word) dot com
PTC's DMD drug given the thumbs down by the EMA. Accelerated approval given in 2014. Its extension trial didnt provide statistically significant data showing benefit.
They are hoping patient groups will help overturn the decision.
For General Information, page-2957
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $89.25M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $35.68K | 354.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 196446 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 238249 | 4 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |